ACL vs NAN

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

51MEDIUM

NAN

NANOSONICS FPO [NAN]

51MEDIUM

Score Breakdown

ACL NAN
Technical
51
48
Catalyst
71
51
Sentiment
50
50
Fundamental
68
94
Momentum
52
38
Risk Gate
36
40

Key Metrics

ACL Metric NAN
$433.7MMarket Cap$899.7M
575KAvg Volume (20d)423K
+6.5%Short Interest+6.8%
$2.97052-Week High$4.770
$1.83352-Week Low$2.960
+0.0%Daily Change-0.7%
$2.330Reference Price$3.030
+16.7%ROE+10.1%
+3.6%Profit Margin+9.9%

Active Signals

ACL Signals

Trading above both moving averages — the trend is your friend here
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
New substantial holder(s) (1)

NAN Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 7.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare ACL and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs NYR →CBL vs NYR →ACL vs NYR →IPD vs LGP →CBL vs LGP →
ACL Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).